BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013;57:201-208. [PMID: 22789139 DOI: 10.1016/j.jcv.2012.04.027] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hossain MG, Ueda K. A meta-analysis on genetic variability of RT/HBsAg overlapping region of hepatitis B virus (HBV) isolates of Bangladesh. Infect Agent Cancer 2019;14:33. [PMID: 31709005 DOI: 10.1186/s13027-019-0253-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Brah S, Moussa S, Inoua A, Alhousseini DM, Daou M, Madougou B, Romera MH, Hamadou A, Adehossi E, Parola P. Molecular characterization of hepatitis B virus from chronically-infected patients in Niamey, Niger. Int J Infect Dis. 2016;45:18-23. [PMID: 26899956 DOI: 10.1016/j.ijid.2016.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Sadeghi A, Shirvani-dastgerdi E, Tacke F, Yagmur E, Poortahmasebi V, Poorebrahim M, Mohraz M, Hajabdolbaghi M, Rasoolinejad M, Abbasian L, Jafari R, Fakhari Z, Norouzi M, Ebrahimian A, Geravand B, Alavian SM, Jazayeri SM. HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg: HBsAg Related Mutations in Occult HBV Infection. J Med Virol 2017;89:246-56. [DOI: 10.1002/jmv.24623] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
4 Holzmayer V, Hance R, Defechereux P, Grant R, Kuhns MC, Cloherty G, Rodgers MA. Identification of hepatitis B virus genotype I in Thailand. J Med Virol 2019;91:717-21. [PMID: 30351478 DOI: 10.1002/jmv.25346] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Su M, Xiang K, Li Y, Li Y, Deng J, Xu X, Yan L, Zhuang H, Li T. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2. Infection, Genetics and Evolution 2016;40:275-81. [DOI: 10.1016/j.meegid.2016.03.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
6 Golsaz-Shirazi F, Mohammadi H, Amiri MM, Khoshnoodi J, Kardar GA, Jeddi-Tehrani M, Shokri F. Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies. Arch Virol 2016;161:2765-72. [PMID: 27439498 DOI: 10.1007/s00705-016-2980-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
7 Chulanov VP, Semenenko TA, Karandashova IV, Komarova SV, Kostyushev DS, Suslov AP, Volchkova EV. Modern View on the Problem of Choosing a Vaccine against Hepatitis B. Epidemiology and Vaccine Prevention 2017;16:65-72. [DOI: 10.31631/2073-3046-2017-16-4-65-72] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
8 Petit PR, Borentain P, Aherfi S, Benezech A, Botta-Fridlund D, Tamalet C, Motte A, Gerolami R, Colson P. Nucleotide and amino acid diversity of hepatitis B virus surface antigen in acute infections, southeastern France. Clin Res Hepatol Gastroenterol 2018;42:e32-4. [PMID: 28927658 DOI: 10.1016/j.clinre.2017.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Liu K, Xie M, Lu X, Yu H, Wang H, Xu Y, Yang Q, Lin Y, Ma Q. Mutations within the major hydrophilic region (MHR) of Hepatitis B virus from individuals with simultaneous HBsAg and anti-HBs in Guangzhou, Southern China. J Med Virol 2018;90:1337-42. [PMID: 29663445 DOI: 10.1002/jmv.25188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 He L, Su M, Ou G, Wang L, Deng J, Zhuang H, Xiang K, Li T. The modulation of HBsAg level by sI126T is affected by additional amino acid substitutions in the S region of HBV. Infect Genet Evol 2019;75:104006. [PMID: 31442597 DOI: 10.1016/j.meegid.2019.104006] [Reference Citation Analysis]
11 Inuzuka T, Ueda Y, Arasawa S, Takeda H, Matsumoto T, Osaki Y, Uemoto S, Seno H, Marusawa H. Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection. Sci Rep 2018;8:18070. [PMID: 30584239 DOI: 10.1038/s41598-018-36093-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
12 Marchio A, Cerapio JP, Ruiz E, Cano L, Casavilca S, Terris B, Deharo E, Dejean A, Bertani S, Pineau P. Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden. Sci Rep 2018;8:12031. [PMID: 30104677 DOI: 10.1038/s41598-018-30229-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Leong J, Lin D, Nguyen MH. Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited. World J Clin Cases 2016; 4(3): 71-75 [PMID: 26989671 DOI: 10.12998/wjcc.v4.i3.71] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
14 Buti M, Tabernero D, Mas A, Homs M, Prieto M, Rodríguez-Frías F, Casafont F, Casillas R, González A, Miras M, Herrero JI, Castells L, Esteban R. Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin. Transpl Infect Dis 2015;17:208-20. [PMID: 25641570 DOI: 10.1111/tid.12360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Li S, Xie M, Li W, Peng Q, Zhong B, Lu X, Ma Q. Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China. Arch Virol 2017;162:2949-57. [DOI: 10.1007/s00705-017-3437-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Lou S, Taylor R, Pearce S, Kuhns M, Leary T. An ultra-sensitive Abbott ARCHITECT® assay for the detection of hepatitis B virus surface antigen (HBsAg). J Clin Virol 2018;105:18-25. [PMID: 29843004 DOI: 10.1016/j.jcv.2018.05.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
17 Luke T, Wu H, Zhao J, Channappanavar R, Coleman CM, Jiao JA, Matsushita H, Liu Y, Postnikova EN, Ork BL, Glenn G, Flyer D, Defang G, Raviprakash K, Kochel T, Wang J, Nie W, Smith G, Hensley LE, Olinger GG, Kuhn JH, Holbrook MR, Johnson RF, Perlman S, Sullivan E, Frieman MB. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med 2016;8:326ra21. [PMID: 26888429 DOI: 10.1126/scitranslmed.aaf1061] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 15.2] [Reference Citation Analysis]
18 Pondé RA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis. 2015;34:1709-1731. [PMID: 26105620 DOI: 10.1007/s10096-015-2422-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
19 Mohraz M, Jafari R, Poortahmasebi V, Sadeghi A, Hajabdolbaghi M, Rasoolinejad M, Forooghi M, Norouzi M, Poorebrahim M, Khamseh A, Karkhaneh M, Alavian SM, Ebrahimian A, Jazayeri SM. Molecular analysis of occult hepatitis B infection among Iranian HIV-positive patients. Future Virology 2016;11:497-508. [DOI: 10.2217/fvl-2016-0032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
20 Harris BJ, Holzmayer V, Qureshi H, Khan MA, Khan SA, Salamat N, Jafri S, Brennan CA. Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors. PLoS One 2017;12:e0178988. [PMID: 28582431 DOI: 10.1371/journal.pone.0178988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 Golsaz-Shirazi F, Shokri F. Hepatitis B immunopathogenesis and immunotherapy. Immunotherapy. 2016;8:461-477. [PMID: 26973127 DOI: 10.2217/imt.16.3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
22 Mayaphi SH, Martin DJ, Mphahlele MJ, Blackard JT, Bowyer SM. Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV. J Med Virol. 2013;85:1883-1892. [PMID: 23925707 DOI: 10.1002/jmv.23695] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
23 Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, Alavian SE, Poortahmasebi V. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon 2016;16:e39097. [PMID: 27642350 DOI: 10.5812/hepatmon.39097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
24 Zhou TC, Li X, Li L, Li XF, Zhang L, Wei J. Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies. Sci Rep 2017;7:661. [PMID: 28386078 DOI: 10.1038/s41598-017-00694-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
25 Simon B, Kundi M, Puchhammer E. Analysis of mutations in the S gene of hepatitis B virus strains in patients with chronic infection by online bioinformatics tools. J Clin Microbiol 2013;51:163-8. [PMID: 23115258 DOI: 10.1128/JCM.01630-12] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
26 Golsaz Shirazi F, Mohammadi H, Amiri MM, Singethan K, Xia Y, Bayat AA, Bahadori M, Rabbani H, Jeddi-tehrani M, Protzer U, Shokri F. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection: Hepatitis B virus neutralizing antibodies. J Gastroenterol Hepatol 2014;29:1083-91. [DOI: 10.1111/jgh.12483] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
27 Chudy M, Scheiblauer H, Hanschmann KM, Kress J, Nick S, Wend U, Schüttler C, Nübling CM, Gerlich WH. Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel. J Clin Virol. 2013;58:47-53. [PMID: 23829967 DOI: 10.1016/j.jcv.2013.06.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
28 Hirzel C, Pfister S, Gorgievski-Hrisoho M, Wandeler G, Zuercher S. Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samples. J Clin Virol 2015;69:33-5. [PMID: 26209374 DOI: 10.1016/j.jcv.2015.05.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Kang Y, Li F, Guo H, Yang S, Zhang Y, Zhu H, Wang J, Mao R, Qin Y, Xu J, Chen X, Wu C, Zhang J. Amino acid substitutions Q129N and T131N/M133T in hepatitis B surface antigen (HBsAg) interfere with the immunogenicity of the corresponding HBsAg or viral replication ability. Virus Res 2018;257:33-9. [PMID: 30179704 DOI: 10.1016/j.virusres.2018.08.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
30 Yang R, Cui L, Liu Y, Cong X, Fei R, Wu S, Wei L. A hook-effect-free homogeneous light-initiated chemiluminescence assay: is it reliable for screening and the quantification of the hepatitis B surface antigen? Ann Transl Med 2020;8:606. [PMID: 32566632 DOI: 10.21037/atm.2020.02.59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pitt SJ, Phillips DI. Diagnostic virology and patient care: from vaguely interesting to vitally important. Br J Biomed Sci 2017;74:16-23. [PMID: 28206853 DOI: 10.1080/09674845.2016.1264706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Brunetto MR. Chance and necessity of simultaneous HBsAg and anti-HBs detection in the serum of chronic HBsAg carriers. Journal of Hepatology 2014;60:473-5. [DOI: 10.1016/j.jhep.2013.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
33 Sadeghi A, Yahyapour Y, Poortahmasebi V, Shahmoradi S, Roggendorf M, Karimzadeh H, Alavian SM, Jazayeri SM. Clearance of HBV DNA in immunized children born to HBsAg-positive mothers, years after being diagnosed with occult HBV infection. J Viral Hepat 2016;23:282-5. [DOI: 10.1111/jvh.12490] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
34 Golsaz-shirazi F, Amiri MM, Bahadori M, Bayat AA, Mohammadi H, Farid S, Maddah M, Khoshnoodi J, Zarnani A, Jeddi-tehrani M, Shokri F. Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface Antigen. Viral Immunology 2015;28:425-33. [DOI: 10.1089/vim.2015.0023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
35 Nicolini LA, Orsi A, Tatarelli P, Viscoli C, Icardi G, Sticchi L. A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals. Int J Environ Res Public Health 2019;16:E3307. [PMID: 31505743 DOI: 10.3390/ijerph16183307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
36 de Campos Albuquerque I, Sousa MT, Santos MD, Nunes JD, Moraes MJ, Gomes-Gouvêa MS, Pinho JR, Carrilho FJ, Fonseca LM, de Sousa Paiva Ferreira A. Mutation in the S gene a determinant of the hepatitis B virus associated with concomitant HBsAg and anti-HBs in a population in Northeastern Brazil. J Med Virol 2017;89:458-62. [PMID: 27486854 DOI: 10.1002/jmv.24653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
37 Walsh R, Hammond R, Yuen L, Deerain J, O'Donnell T, Leary T, Cloherty G, Gaggar A, Kitrinos K, Subramanian M, Wong D, Locarnini S. Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: A biomarker for functional cure. Liver Int. 2019;39:2066-2076. [PMID: 31379058 DOI: 10.1111/liv.14207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
38 Martiskainen I, Talha SM, Vuorenpää K, Salminen T, Juntunen E, Chattopadhyay S, Kumar D, Vuorinen T, Pettersson K, Khanna N, Batra G. Upconverting nanoparticle reporter-based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigen. Anal Bioanal Chem 2021;413:967-78. [PMID: 33230700 DOI: 10.1007/s00216-020-03055-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Angata K, Wagatsuma T, Togayachi A, Sato T, Sogabe M, Tajiri K, Ozawa T, Nagashima I, Shimizu H, Iijima S, Korenaga M, Kuno A, Kaji H, Mizokami M, Narimatsu H. O-glycosylated HBsAg peptide can induce specific antibody neutralizing HBV infection. Biochim Biophys Acta Gen Subj 2022;1866:130020. [PMID: 34582939 DOI: 10.1016/j.bbagen.2021.130020] [Reference Citation Analysis]
40 Colson P, Borentain P, Coso D, Motte A, Aurran-Schleinitz T, Charbonnier A, Stoppa AM, Chabannon C, Serrero M, Bertrand J, Barlesi F, Serratrice J, Portal I, Botta-Fridlund D, Tamalet C, Gerolami R. Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase. Virology. 2015;484:354-363. [PMID: 26186574 DOI: 10.1016/j.virol.2015.06.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
41 Xiang KH, Michailidis E, Ding H, Peng YQ, Su MZ, Li Y, Liu XE, Dao Thi VL, Wu XF, Schneider WM. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA. J Hepatol. 2017;66:288-296. [PMID: 27650283 DOI: 10.1016/j.jhep.2016.09.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
42 Liu Y, Zhang L, Zhou JY, Pan J, Hu W, Zhou YH. Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs. PLoS One 2016;11:e0146980. [PMID: 26751075 DOI: 10.1371/journal.pone.0146980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
43 Chenari M, Norouzi M, Ghalichi L, Rezaee A, Yari A, Alavian SM, Jazayeri SM. Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area. J Med Virol 2014;86:1861-7. [PMID: 25132488 DOI: 10.1002/jmv.24046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
44 Jiang X, Chang L, Yan Y, Wang L. Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences. Int J Biol Sci 2021;17:1125-37. [PMID: 33867835 DOI: 10.7150/ijbs.55724] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Golsaz-shirazi F, Amiri MM, Farid S, Bahadori M, Bohne F, Altstetter S, Wolff L, Kazemi T, Khoshnoodi J, Hojjat-farsangi M, Chudy M, Jeddi-tehrani M, Protzer U, Shokri F. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg). Antiviral Research 2017;144:153-63. [DOI: 10.1016/j.antiviral.2017.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
46 Osiowy C, Kowalec K, Giles E. Discordant diagnostic results due to a hepatitis B virus T123A HBsAg mutant. Diagnostic Microbiology and Infectious Disease 2016;85:328-33. [DOI: 10.1016/j.diagmicrobio.2016.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
47 Berg MG, Olivo A, Forberg K, Harris BJ, Yamaguchi J, Shirazi R, Gozlan Y, Sauleda S, Kaptue L, Rodgers MA, Mor O, Cloherty GA. Advanced molecular surveillance approaches for characterization of blood borne hepatitis viruses. PLoS One 2020;15:e0236046. [PMID: 32678844 DOI: 10.1371/journal.pone.0236046] [Reference Citation Analysis]
48 Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Selabe SG, Gededzha MP, Mayaphi SH, Powell EA, Blackard JT, Mphahlele MJ. Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants. J Clin Virol 2015;63:12-7. [PMID: 25600597 DOI: 10.1016/j.jcv.2014.11.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
49 Baclig MO, Alvarez MR, Gopez-cervantes J, Natividad FF. Unique surface gene variants of hepatitis B virus isolated from patients in the Philippines: Hepatitis B Surface Antigen Variants. J Med Virol 2014;86:209-16. [DOI: 10.1002/jmv.23717] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]